(Q35785971)

10 August 2017

title

Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase (English)

1 reference

10 August 2017

N Mitsiades

1

1 reference

10 August 2017

V Poulaki

2

1 reference

10 August 2017

V Kotoula

3

1 reference

10 August 2017

A Leone

4

1 reference

10 August 2017

M Tsokos

5

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

The American Journal of Pathology

10 August 2017

published in

1 reference

10 August 2017

volume

153

1 reference

10 August 2017

issue

6

1 reference

10 August 2017

page(s)

1947-1956

1 reference

Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Downregulation of Fas ligand by shedding

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Matrix metalloproteinase inhibitors: present achievements and future prospects

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Changing views of the role of matrix metalloproteinases in metastasis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Expression of Fas ligand in liver metastases of human colonic adenocarcinomas

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

The matrix metalloproteinases and their inhibitors in pancreatic cancer. From molecular science to a clinical application

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Human lung carcinomas express Fas ligand.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Matrix metalloproteinases and processing of pro-TNF-alpha.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Expression of the functional soluble form of human fas ligand in activated lymphocytes.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Reverse transcriptase PCR amplification of EWS/FLI-1 fusion transcripts as a diagnostic test for peripheral primitive neuroectodermal tumors of childhood

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Metalloproteinase-mediated release of human Fas ligand

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Human tumor cell heterogeneity and metastasis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Use of NeoR B16F1 murine melanoma cells to assess clonality of experimental metastases in the immune-deficient chick embryo.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Cytogenetic characterization of selected small round cell tumors of childhood

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Olfactory neuroblastoma is not a neuroblastoma but is related to primitive neuroectodermal tumor (PNET).

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Origin and biology of cancer metastasis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

12 July 2018

Metastatic Inefficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866328

Fas ligand in human serum

25 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965708-2

Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965708-2

Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965708-2

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965708-2

A role for CD95 ligand in preventing graft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965708-2

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965708-2

An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965708-2

Constitutive expression of Fas ligand in large granular lymphocyte leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965708-2

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965708-2

Evidence for the clonal origin of spontaneous metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965708-2

Processing of tumour necrosis factor-α precursor by metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965708-2

Involvement of a metalloprotease in the shedding of human neutrophil Fc gammaRIIIB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965708-2

Involvement of the membrane form of tumour necrosis factor-alpha in lipopolysaccharide-induced priming of mouse peritoneal macrophages for enhanced nitric oxide response to lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965708-2

Matrix metalloproteinase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965708-2

Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9846984

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9846984

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/S0002-9440(10)65708-2

1 reference

10 August 2017

1 reference

10 August 2017

1 reference